Clearbridge Advisors LLC 13D/13G Filings for Ionis Pharmaceuticals, Inc. (IONS)

Clearbridge Advisors LLC 13D and 13G filings for Ionis Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-09
5:23 pm
Sale
2020-12-31 13G Ionis Pharmaceuticals, Inc.
IONS
Clearbridge Advisors LLC 6,915,147
4.950%
-1,032,429decrease
(-12.99%)
Filing